About Copine-2
Copine-2 (CPNE2) is a protein
from Homo sapiens identified by UniProt accession
Q96FN4, 548 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Copine-2 |
| UniProt accession | Q96FN4 |
| Gene | CPNE2 |
| Organism | Homo sapiens |
| Length | 548 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (19)
Diseases linked to this target (Open Targets).
- eosinophil count · score 0.15
- neurodegenerative disease · score 0.11
- lymphocyte count · score 0.08
- metabolite measurement · score 0.07
- lymphocyte percentage of leukocytes · score 0.07
- eosinophil percentage of leukocytes · score 0.07
- breast milk measurement · score 0.05
- neutrophil percentage of leukocytes · score 0.05
- multiple sclerosis · score 0.05
- mean corpuscular hemoglobin concentration · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96FN4-F1 | alphafold | PREDICTED | 91.09 | — |
Amino-acid sequence (548 residues)
MAHIPSGGAP AAGAAPMGPQ YCVCKVELSV SGQNLLDRDV TSKSDPFCVL FTENNGRWIE YDRTETAINN LNPAFSKKFV LDYHFEEVQK LKFALFDQDK SSMRLDEHDF LGQFSCSLGT IVSSKKITRP LLLLNDKPAG KGLITIAAQE LSDNRVITLS LAGRRLDKKD LFGKSDPFLE FYKPGDDGKW MLVHRTEVIK YTLDPVWKPF TVPLVSLCDG DMEKPIQVMC YDYDNDGGHD FIGEFQTSVS QMCEARDSVP LEFECINPKK QRKKKNYKNS GIIILRSCKI NRDYSFLDYI LGGCQLMFTV GIDFTASNGN PLDPSSLHYI NPMGTNEYLS AIWAVGQIIQ DYDSDKMFPA LGFGAQLPPD WKVSHEFAIN FNPTNPFCSG VDGIAQAYSA CLPHIRFYGP TNFSPIVNHV ARFAAQATQQ RTATQYFILL IITDGVISDM EETRHAVVQA SKLPMSIIIV GVGNADFAAM EFLDGDSRML RSHTGEEAAR DIVQFVPFRE FRNAAKETLA KAVLAELPQQ VVQYFKHKNL PPTNSEPA
Explore Copine-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets